REVIEW article
Front. Oncol.
Sec. Cancer Molecular Targets and Therapeutics
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1546875
This article is part of the Research TopicUnraveling Radiation Therapy's Role in Tumor Immunology and Systemic Antitumor ResponsesView all 3 articles
Potential Immunogenic Modulation of Hypo-fractionated Radiotherapy at Optimal Schedules and the Subsequent Vaccine-Like Effect of Local Irradiation - A Systematic Review
Provisionally accepted
- 1Griffith Health, Griffith University, Southport, Australia
- 2The University of Melbourne, Parkville, Victoria, Australia
- 3GenesisCare (Australia), Wembley, Western Australia, Australia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: Hypo-fractionated radiotherapy (HFRT) regimens can induce immune system activation and help to identify a therapeutic window after RT by measuring cytotoxic T-cell concentration. Here, we summarise previous preclinical and clinical studies on the effects of HFRT on the immune system, both locally and systemically. We also investigate the existing data on the optimal dose and fractionation scheme of HFRT to enhance local and distant anti-tumour immunity. Methods: A search was conducted using the PubMed, ScienceDirect, and Google Scholar databases. The systematic review was conducted in accordance with the PRISMA-DTA guidelines. Quality was assessed utilising the Prediction model Risk Of Bias ASsessment Tool (PROBAST). Data from publications that met quality criteria were grouped via (1) hypo-fractionated radiotherapy, (2) CD8+ T-cells infiltration, (3), immune stimulation, and (4) abscopal effect. Results: After eligibility consideration, 12 studies (7 = preclinical and 5 = clinical) were selected for this systematic review article. Ten of the 12 studies observed T-cell infiltration into the tumour environment following HFRT. Moreover, six of 12 preclinical and clinical studies tested the HFRT schemes with several-day intervals to control tumour growth. To assess the possible immunogenic impact of HFRT on the immune system both locally and systemically, eight previous studies examined the abscopal effect (AE) and response rates following optimal HFRT schedules. Conclusions: Existing literature suggests that HFRT with an optimal regimen can induce the activation of T lymphocytes and break tumour tolerance while simultaneously reducing the frequency of Tregs. The collected studies also suggested that optimal dosages and fractions of HFRT induce an immune response. However, it should be further explored to provide clinicians with information that would be valuable when making decisions regarding patient care. This strategy may simplify protocols, increase cancer patients' response rate to treatment, lower costs, and lower their chance of toxicity and developing immune-related side effects after receiving chemotherapy and immunotherapy.
Keywords: hypo-fractionated radiotherapy, CD8+ T-cells infiltration, Immune stimulation, abscopal effect, clinical outcomes
Received: 17 Dec 2024; Accepted: 22 Sep 2025.
Copyright: © 2025 Singh, Ashdown and Baxi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jagtar Singh, jagtar.singh@griffith.edu.au
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.